Boston University Medical School Releases Low-UVC/Covid-19 Inactivation Results for the halō
BOSTON, MA (17 February 2021) - Boston University Medical School and LUV SYSTEMS, INC. report a 99.9% kill rate of the Covid-19 virus within seconds, at under 5 mJ/cm2, using the light fixture in the the halō Model 5R/M air disinfection. the halō is the first of multiple low-wavelength ultraviolet (low-UVC) disinfection products by LUV Systems. The experiment was performed by Dr. Anthony Griffiths at Boston University Medical School, the first researcher worldwide to report results of Covid-19 virion inactivation with UVC. The patent-pending Model 5R/M has a fan and LUVTM light ring, which together “carry your breath up and away” in a room’s breathing zone, disinfect it with low-UVC lights, and return clean air back down into the breathing zone. LUV Systems products are:
- PROVEN against Covid-19 and most pathogens;
- SAFE for people and pets in occupied spaces; and,
- AFFORDABLE for personal/commercial markets
Anu Sood, CEO of LUV Systems, states "according to results issued by our Principal Investigator Dr. Anthony Griffiths at Boston University Medical School, the halō's light fixture achieved 99.9% inactivation of the Covid-19 virus within seconds and as we fully expected.”
Next steps, according to Sood, include “final data validation of these results from Boston University and further surface exposure trials with 207, 222, 235, and 245 nm low-UVC wavelengths.” Danish Khatri, Principal Engineer, adds, “we’re thrilled that our independent testing validated our theoretical calculations, and we look forward to continued work with Dr. Griffiths using additional light energies with the Covid-19 virus.”
Neeraj Chaudhary, Business Analyst, notes that LUV Systems products offer “affordable consumer and commercial products to accelerate the safe reopening of economies, while providing necessary peace of mind as people return to a state of normal in homes, offices, schools, retail and entertainment establishments, and transportation systems.”
Sood is encouraged by progress to date, including “patent applications and actions, lab research on real-world surfaces with the halō's light fixture and UVC inactivation of SARS-CoV-2, dose calculation, prototype validation testing, and sourcing and production contracts.” For indoor air disinfection, LUV Systems has a proprietary dose algorithm to correlate viral inactivation surface results with indoor air disinfection dose rates.
Ultraviolet disinfection technology has been used for over 100 years in many applications including hospitals, laboratories, and water treatment facilities. LUV Systems products are designed with a 100x safety margin for acceptable exposures as established by FCC for devices such as cell phones.
LUV Systems’ LUVTM product line includes personal and installed devices to disinfect surfaces and air while people are present and conducting their normal activities, without direct human exposure. LUVTM air disinfection products are designed to clear indoor spaces in less than five minutes, which is 3X faster than the CDC’s published 15-minute guideline for indoor air.
LUV Systems products currently incorporate engineering controls such as motion sensors to automatically control and monitor device operation. Future product releases are planned with body temperature, tilt, and distance sensors, plus algorithms including a mobile app.
LUV Systems inventions are designed in America and Sood states “the products can easily be 100% manufactured in the United States. We continue to seek business and governmental partners to continue research and development, secure international patents, and establish a manufacturing and distribution pipeline.”
Leave a comment